Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45,930 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients.
Guan S, Chen X, Wang F, Xin S, Feng W, Zhu X, Liu S, Zhuang W, Zhou S, Huang M, Wang X, Zhang L. Guan S, et al. Among authors: wang x, wang f. J Pharm Biomed Anal. 2019 Aug 5;172:364-371. doi: 10.1016/j.jpba.2019.03.060. Epub 2019 Mar 28. J Pharm Biomed Anal. 2019. PMID: 31096095
Establishment and application of a predictive model for gefitinib-induced severe rash based on pharmacometabolomic profiling and polymorphisms of transporters in non-small cell lung cancer.
Guan S, Chen X, Xin S, Liu S, Yang Y, Fang W, Huang Y, Zhao H, Zhu X, Zhuang W, Wang F, Feng W, Zhang X, Huang M, Wang X, Zhang L. Guan S, et al. Among authors: wang x, wang f. Transl Oncol. 2021 Jan;14(1):100951. doi: 10.1016/j.tranon.2020.100951. Epub 2020 Nov 19. Transl Oncol. 2021. PMID: 33221684 Free PMC article.
Rational application of gefitinib in NSCLC patients with sensitive EGFR mutations based on pharmacokinetics and metabolomics.
Feng W, Chen X, Guan SX, Ruan HL, Huang Y, Zhang HZ, Yang YP, Fang WF, Zhao HY, Zhuang W, Xin S, Chen YH, Wang F, Gao Y, Huang M, Wang XD, Zhang L. Feng W, et al. Among authors: wang xd, wang f. Acta Pharmacol Sin. 2022 Jul;43(7):1857-1864. doi: 10.1038/s41401-021-00791-5. Epub 2021 Nov 4. Acta Pharmacol Sin. 2022. PMID: 34737420 Free PMC article.
Epidermal growth factor receptor inhibitors as adjuvant treatment for patients with resected non-small cell lung cancer harboring EGFR mutation: a meta-analysis of randomized controlled clinical trials.
Zhao N, Wu ZP, Yang J, Feng WN, Yang SL, Luo Y, Ye J, Wang F, Zhang XW, Xiao Y, Wu LL, Gu WQ. Zhao N, et al. Among authors: wang f. World J Surg Oncol. 2023 Feb 13;21(1):45. doi: 10.1186/s12957-023-02925-x. World J Surg Oncol. 2023. PMID: 36782320 Free PMC article. Review.
45,930 results
You have reached the last available page of results. Please see the User Guide for more information.